These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 35261120)

  • 21. Misoprostol use under routine conditions for termination of pregnancies with intrauterine fetal death.
    Nascimento MI; Cunha Ade A; Oliveira SR; Nunes GG; Alvarez FS; Villas Bôas EL
    Rev Assoc Med Bras (1992); 2013; 59(4):354-9. PubMed ID: 23850023
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized comparison of vaginal (200 microg every 3 h) and oral (400 microg every 3 h) misoprostol when combined with mifepristone in termination of second trimester pregnancy.
    Ngai SW; Tang OS; Ho PC
    Hum Reprod; 2000 Oct; 15(10):2205-8. PubMed ID: 11006200
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral misoprostol vs. vaginal misoprostol for termination of pregnancy with intrauterine fetal demise in the second-trimester.
    Fadalla FA; Mirghani OA; Adam I
    Int J Gynaecol Obstet; 2004 Jul; 86(1):52-3. PubMed ID: 15207678
    [No Abstract]   [Full Text] [Related]  

  • 24. Low-dose vaginal misoprostol with or without Foley catheter for late second-trimester pregnancy termination in women with previous multiple cesarean sections.
    El Sharkwy IAE; Elsayed ML; Ahmed MA; Alnemer AAA
    J Matern Fetal Neonatal Med; 2019 Nov; 32(22):3703-3707. PubMed ID: 29742942
    [No Abstract]   [Full Text] [Related]  

  • 25. Two regimens of vaginal misoprostol in second trimester termination of pregnancy: a prospective randomised trial.
    Bhattacharyya SK; Mukherji J; Kamilya GS; Ray S; Hazra A
    Acta Obstet Gynecol Scand; 2006; 85(12):1458-62. PubMed ID: 17260222
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Second trimester pregnancy termination with 400 μg vaginal misoprostol: efficacy and safety.
    Kunwar S; Saha PK; Goel P; Huria A; Tandon R; Sehgal A
    Biosci Trends; 2010 Dec; 4(6):351-4. PubMed ID: 21248435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vaginal versus oral misoprostol for second-trimester pregnancy termination: a randomized trial.
    Behrashi M; Mahdian M
    Pak J Biol Sci; 2008 Nov; 11(21):2505-8. PubMed ID: 19205272
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized comparison of dry tablet insertion versus gel form of vaginal misoprostol for second trimester pregnancy termination.
    Pongsatha S; Tongsong T
    J Obstet Gynaecol Res; 2008 Apr; 34(2):199-203. PubMed ID: 18412782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complications of second-trimester medical termination of pregnancy for fetal anomalies compared with intrauterine fetal demise.
    Testani E; Latta K; Barker E; York SL; Laursen L
    Int J Gynaecol Obstet; 2023 Jan; 160(1):145-149. PubMed ID: 35695042
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness and adverse effects of vaginal misoprostol as a single agent for second trimester pregnancy termination: the impact of fetal viability.
    Pongsatha S; Suntornlimsiri N; Tongsong T
    Arch Gynecol Obstet; 2024 Apr; 309(4):1459-1466. PubMed ID: 37149516
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Second-trimester pregnancy termination with 600-microg vs. 400-microg vaginal misoprostol and systematic curettage postexpulsion: a randomized trial.
    Carbonell JL; Torres MA; Reyes R; Ortega L; García-Gallego F; Sánchez C
    Contraception; 2008 Jan; 77(1):50-5. PubMed ID: 18082667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Use of misoprostol for induction of labor in case of fetal death or termination of pregnancy during second or third trimester of pregnancy: Efficiency, dosage, route of administration, side effects, use in case of uterine scar].
    Clouqueur E; Coulon C; Vaast P; Chauvet A; Deruelle P; Subtil D; Houfflin-Debarge V
    J Gynecol Obstet Biol Reprod (Paris); 2014 Feb; 43(2):146-61. PubMed ID: 24461423
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Misoprostol moistened with acetic acid or saline for second trimester pregnancy termination: a randomized prospective double-blind trial.
    Yilmaz B; Kelekci S; Ertas IE; Kahyaoglu S; Ozel M; Sut N; Danisman N
    Hum Reprod; 2005 Nov; 20(11):3067-71. PubMed ID: 16037107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of intravenous oxytocin to vaginal misoprostol for mid trimester labor induction.
    Hidar S; Jerbi M; Khaïri H
    Am J Obstet Gynecol; 2006 Jul; 195(1):332-3; author reply 333-4. PubMed ID: 16813766
    [No Abstract]   [Full Text] [Related]  

  • 35. A comparison of two regimens of misoprostol for second trimester medical termination of pregnancy: a randomized trial.
    Chaudhuri S; Banerjee PK; Mundle M; Mitra SN
    Trop Doct; 2010 Jul; 40(3):144-8. PubMed ID: 20555044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Late second-trimester abortions induced with mifepristone, misoprostol and oxytocin: a report of 428 consecutive cases.
    Esteve JL; Gallego FG; Llorente MP; Bermúdez SB; Sala ES; González LV; Texidó CS
    Contraception; 2008 Jul; 78(1):52-60. PubMed ID: 18555818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized comparative study on vaginal administration of acetic acid-moistened versus dry misoprostol for mid-trimester pregnancy termination.
    Bhattacharjee N; Saha SP; Ganguly RP; Patra KK; Jha T; Barui G; Saha M
    Arch Gynecol Obstet; 2012 Feb; 285(2):311-6. PubMed ID: 21735193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Misoprostol for induction of labour: a systematic review.
    Hofmeyr GJ; Gülmezoglu AM; Alfirevic Z
    Br J Obstet Gynaecol; 1999 Aug; 106(8):798-803. PubMed ID: 10453829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of two regimens of misoprostol for early second-trimester pregnancy termination.
    Guix C; Palacio M; Figueras F; Bennasar M; Zamora L; Coll O; Cararach V
    Fetal Diagn Ther; 2005; 20(6):544-8. PubMed ID: 16260893
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Efficacy and safety of mifepristone combined with misoprostol for termination of pregnancy between 8 and 16 weeks of gestation].
    Qian J; Jing X; Wu S; Zheng S; Li Y; Ren M; Di W; Shen H; Dong B; Chang Q; Shi H; Yao C; Song W; Huang Z
    Zhonghua Fu Chan Ke Za Zhi; 2015 Jul; 50(7):505-9. PubMed ID: 26311640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.